L. Ma et al., ROLE OF EPIDERMAL-GROWTH-FACTOR RECEPTOR IN TUMOR PROGRESSION IN TRANSFORMED HUMAN MAMMARY EPITHELIAL-CELLS, International journal of cancer, 78(1), 1998, pp. 112-119
The presence of epidermal-growth-factor receptors (EGFR) and of its li
gands (TGF alpha: and amphiregulin) in breast-cancer tissues suggests
that they play a paracrine/autocrine role in tumor growth or progressi
on. This hypothesis was tested on 3 cell lines, S2T2, NS2T2A and NS2T2
A1. These epithelial cells are derived from a normal human breast-epit
helial-cell culture transformed by SV40-T Ag, are of the same clonal o
rigin, have respectively increasing levels of EGFR, TGF alpha, amphire
gulin and of thymidine-kinase activity associated with increasing tumo
rigenic potential in nude mice (tumor intake and tumor volume). The mo
noclonal antibody MAb 425, which blocks ligands interaction with EGFR,
reduced by more than 90% anchorage-independent growth of the most tum
origenic cells, NS2T2A I. Another anti-EGFR MAb, 528, reduced to 25% o
f controls the mean tumor mass after NS2T2A1 grafting in mice. Anti-se
nse RNA expression of EGFR in these cells confirmed the importance of
this receptor in tumor progression, since it reduced significantly the
tumor volume and tumor weight of NS2T2A1 cells to 16% of those in moc
k-transfected control cells. (C) 1998 Wiley-Liss, Inc.